Meetings to be held June 15-16 hosted by Oppenheimer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CLRB:
- Cellectar Biosciences management to meet with Oppenheimer
- Cellectar Biosciences expects topline data from WM CLOVER-WaM trial in 2H23
- Cellectar Provides a Research and Development Program Summary
- CLRB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- UPDATE — Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update